Related Experiment Video
Updated: May 10, 2026
10:03
Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
[Cardiac natriuretic peptides and hypertension: experimental study].
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
|June 29, 2013
Summary
Cardiac natriuretic peptide secretion is elevated in ISIAH rats before hypertension develops. These peptides play a role in blood pressure regulation throughout life and contribute to hypertension.
Area of Science:
- Cardiology
- Endocrinology
- Physiology
Background:
- Cardiac natriuretic peptides are crucial for cardiovascular homeostasis.
- Inherited stress-induced arterial hypertension (ISIAH) rat model exhibits unique physiological characteristics.
- Ontogenesis involves significant developmental changes in cardiac function.
Purpose of the Study:
- To investigate cardiac natriuretic peptide secretion during ontogenesis in ISIAH rats.
- To compare hormonal activity in ISIAH rats with normotensive controls.
- To elucidate the role of natriuretic peptides in the development of inherited hypertension.
Main Methods:
- Hypertonic disease model in ISIAH rats.
- Qualitative and quantitative ultrastructural investigations of right atrium myocardium.
- Comparative analysis with normotensive control rats.
Main Results:
- ISIAH rats exhibit higher cardiac hormonal synthetic and secretory activity compared to normotensive rats.
- Secretory hyperactivity of atrial myocytes in ISIAH rats precedes hypertension onset.
- Natriuretic peptides function as a hypotensive regulatory circuit throughout ontogeny.
Conclusions:
- Elevated natriuretic peptide secretion is an early characteristic of ISIAH rats.
- Natriuretic peptides are integral to hemodynamic regulation and hypertension development.
- Understanding these mechanisms offers insights into managing inherited hypertension.
More Related Videos
Related Concept Videos
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:17Hormonal Regulation of Blood Pressure
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...